Roche's Genentech Gets FDA Approval for Lung-Cancer Treatment - Morningstar

Retrieved on: 2024-04-18 22:12:37

Tags for this article:

Lung cancer

Alectinib

Anaplastic lymphoma kinase

Non-small-cell lung cancer

Small-cell carcinoma

ALK positive lung cancer

Roche Group

u.s. food and drug administration

Click the tags to see associated articles and topics

Roche's Genentech Gets FDA Approval for Lung-Cancer Treatment - Morningstar. View article details on hiswai:

Excerpt

By Ben Glickman. Roche Group-member Genentech said Thursday it had received regulatory approval for its treatment for patients with an early-stage ...

Article found on: www.morningstar.com

View Original Article